3/2/2020

Automated iPSC manufacturing, one person's iPSC in 3 months（NIKKEI）

3/2/2020

I Peace, Automated iPSC Mass Manufacturing System: Production in 3 months at minimum（NIKKAN KOGYO SHIMBUN）

5/15/2020

I Peace, New iPSC Service with fully automated nanufacturing（NIKKEI）

5/25/2021

I Peace's cell manufacturing facility "Peace Engine Kyoto" receives third-party certification as US cGMP compliant: the facility now meets the standard for both the US and Japanese markets (Bioinformant)

6/1/2020

The article about I Peace’s iPSC manufacturing service was posted on the KYODO NEWS. Unfortunately the article is not currently available.

7/28/2020

I Peace begins manufacturing iPSC for personal use in Kyoto (NIKKEI）

8/1/2021

KOJI TANABE, CEO OF I PEACE, INC. - INTERVIEW WITH WBM TOP 100 INNOVATION CEO (World Business Magazine)

12/28/2020

I Peace collaborates with U.S. biotech venture on iPSC-derived cell therapy for heart diseases（NIKKAN KOGYO SHIMBUN）

3/22/2021

I Peace, foundeed by a Kyoto Univ. Alumni, begins providing iPSCs（NIKKEI）

3/25/2021

Manufacturing and Selling iPSC: Interview with the Japanese Founder（ABEMA News）

3/27/2021

Hair regeneration, anti-aging... Is this the age of Personal iPSCs? The manufacturing cost for iPSCs that used to be \100 million is now going down（ABEMA Times）

6/6/2021

iPSC Production and Storage Service for individuals offered by a private company: In preparation for regenerative medicine in the future.（The Asahi Shimbun）

7/27/2021

I Peace, collaborate with IROM Group in iPSC manufacturing and storage, plans to expand nationwide in October.（NIKKAN KOGYO SHIMBUN）

10/13/2021

I Pace’s iPSC manufacturing facility in Kyoto, Japan, registered with FDA, listed in the database（NIKKAN KOGYO SHIMBUN）

01/27/2022

I Peace's Cell Manufacturing Facility "Peace Engine Kyoto" now registered as U.S. FDA Drug Establishment (Bio Space)

3/9/2022

I Peace triples iPSC Manufacturing capacityby expanding it’s clean room　（NIKKAN KOGYO SHIMBUN）

3/10/2022

I Peace triples iPSC manufacturing capacity to meet growing demand（NEWSWITCH）

3/15/2022

CDMO I Peace expansion triples capacity to manufacture induced pluripotent stem cells (Fierce Pharma)

3/17/2022

Palo Alto CDMO boosts induced pluripotent stem cell manufacturing capacity (Bio Pharma Reporter)

3/17/2022

I Peace to streamline donor sourcing, help advance drug discovery and cell transplantation therapy（NIKKAN KOGYO SHIMBUN）

3/17/2022

Manufacturing roundup: Vector Labs expands in Bay Area; Boulder biotech enlists East Coast CDMO (Endpoints News)

3/20/2022

Genequest and I Peace, facilitate smooth discovery of donors with specific genotypes by utilizing iPSC（NIKKEI）

3/23/2022

Californian CDMO triples iPS capacity with $10m investment (Bio Process International)

6/3/2022

I Peace obtains a license to manufacture specific cell-based products for the expanded portion of its cell processing facility （NIKKEI BIO TECH ONLINE）

6/4/2022

A new automated iPSC high-throughput induction system to induce thousands of iPSC lines simultaneously: To be presented at ISSCR 2022 Annual Meeting(Bio Space)

7/1/2022

I Peace triples production capacity for iPSC and other cell products（NIKKEI）

7/14/2022

I Peace directly converts skin cells to target cells bypassing iPSC（NIKKAN KOGYO SHIMBUN）

8/2/2022

I Peace generates neuronal cells directly from skin cells（NIKKEI）

9/15/2022

GMP cell CDMO I Peace, Inc. succeeded in converting human dermal fibroblasts into oligodendrocyte precursor cells by direct reprogramming in joint research with Stanford University and the University of California (UCSF) (Bioinformant)

10/10/2022

Seen on video. Manufacture and store your own iPS cells, starting at 2 million yen（NIKKEI）

10/22/2022

iPSC-derived cell therapy enters a new era! GMP-spec automated high-throughput amplification system induces thousands of iPSCs simultaneously

10/26/2022

The 2022 International Cell Therapy and Regenerative Medicine Summit was held in Taichung Veterans General Hospital.

11/1/2022

I Peace partners with the California Institute for Regenerative Medicine [CIRM] (BioSpace)

11/1/2022

I Peace partners with a California state agency and agrees to provide clinical grade iPSCs.（NIKKAN KOGYO SHIMBUN）

11/2/2022

I Peace partners with the California Institute for Regenerative Medicine [CIRM] (BioPharma APAC)

11/3/2022

I Peace partners with the California Institute for Regenerative Medicine [CIRM] (BioSpectrum Asia)

11/21/2022

BioSpectrum Asia announces Editor’s Choice Award Winners for 2022 (BioSpectrum Asia)

Special Recognition in Cell Therapy for the Year 2022

The 7th Japan Entrepreneur Awards in Health care (Medical)

CEO Koji Tanabe World Biz Magazine TOP 100 CEOS IN INOVATION 2021(World Biz Magazine)